Osteoporosis Awareness in Rheumatoid Arthritis Patients
Knowledge and Awareness of Osteoporosis in Rheumatoid Arthritis Patients
1 other identifier
observational
100
1 country
1
Brief Summary
Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Rheumatoid arthritis patients are at increased risk for developing osteoporosis. It is crucial to identify whether rheumatoid arthritis patients know and know about this disease. This study investigates awareness and knowledge of osteoporosis in rheumatoid arthritis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 27, 2022
CompletedFirst Posted
Study publicly available on registry
February 22, 2023
CompletedStudy Start
First participant enrolled
April 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedFebruary 22, 2023
February 1, 2023
3 months
December 27, 2022
February 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Level of knowledge in osteoporosis
Level of knowledge in osteoporosis will be assessed with revised osteoporosis knowledge test (OKT). The Revised OKT (2012) is a comprehensive instrument reflecting current research and assesses osteoporosis knowledge of adults. Responses offered to participants are multiple choice (e.g., for risk items: more likely, less likely, neutral, don't know), there is only one correct answer for each item. Responses are dichotomously recoded as correct or incorrect. In a U.S. sample of adults, the measure demonstrated internal consistency, very good stability, and content validity. Point-biserial correlations supported the measure's validity.
1 day
Study Arms (1)
Rheumatoid Arthritis Patients
Patients that are diagnosed with rheumatoid arthritis
Interventions
Patients will be asked to fill out a patient information form and an osteoporosis awareness form
Eligibility Criteria
Patients aged 18 to 90 years with a diagnosis of rheumatoid arthritis who gave consent to participate in the study.
You may qualify if:
- Clinical diagnosis of rheumatoid arthritis
- Must be between the ages of 18 and 90
- Must give consent to participate in the study
You may not qualify if:
- Not giving consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Üsküdar State Hospital
Istanbul, Üsküdar, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mustafa H Temel, M.D.
Uskudar State Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 27, 2022
First Posted
February 22, 2023
Study Start
April 30, 2023
Primary Completion
July 30, 2023
Study Completion
August 30, 2023
Last Updated
February 22, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share